title: Neuropathology in mice expressing mouse alpha-synuclein.
abstract: α-Synuclein (αSN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (mαSN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express mαSN in central neurons at levels reaching up to six-fold compared to endogenous mαSN. Unlike transgenic mice expressing human wildtype or mutant forms of αSN, these mαSN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of mαSN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated αSN occurred in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated αSN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in mαSN transgenic mice, was similar to what we have reported for mice expressing human αSN wildtype or mutant forms. In hippocampal neurons, the mαSN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human αSN, mαSN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype mαSN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.
authors.affiliation: Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
authors.forename: Claus
authors.initials: C
authors.lastname: Rieker
authors.forename: Kumlesh K
authors.initials: KK
authors.lastname: Dev
authors.forename: Katja
authors.initials: K
authors.lastname: Lehnhoff
authors.forename: Samuel
authors.initials: S
authors.lastname: Barbieri
authors.forename: Iwona
authors.initials: I
authors.lastname: Ksiazek
authors.forename: Sabine
authors.initials: S
authors.lastname: Kauffmann
authors.forename: Simone
authors.initials: S
authors.lastname: Danner
authors.forename: Heinrich
authors.initials: H
authors.lastname: Schell
authors.forename: Cindy
authors.initials: C
authors.lastname: Boden
authors.forename: Markus A
authors.initials: MA
authors.lastname: Ruegg
authors.forename: Philipp J
authors.initials: PJ
authors.lastname: Kahle
authors.forename: Herman
authors.initials: H
authors.lastname: van der Putten
authors.forename: Derya R
authors.initials: DR
authors.lastname: Shimshek
mesh_terms: D000818:Animals; D001369:Axons / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D015870:Gene Expression; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D018782:Maze Learning / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D016253:Microscopy, Immunoelectron; D009043:Motor Activity / Q000502:physiology; D009422:Nervous System Diseases / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D010766:Phosphorylation; D013116:Spinal Cord / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D025801:Ubiquitin / Q000378:metabolism; D051844:alpha-Synuclein / Q000235:genetics* / Q000378:metabolism
chemical_list: D025801:Ubiquitin; D051844:alpha-Synuclein